Depression and PTSD symptoms in caregivers of lung transplant patientsMay 19, 2008Symptoms of depression and post-traumatic stress disorder (PTSD) among caregivers of deceased lung transplant patients are four-to-five times more prevalent than in the average population, according to researchers who analyzed the stress levels of caregivers, as well as their perceptions of the transplant recipients' quality of dying and death. Their findings were presented at the American Thoracic Society's 2008 International Conference in Toronto on Monday, May 19. Caregivers of all lung transplant recipients at the University of Washington who had died within the last five years were assessed using three validated questionnaires that measured their burden of depression, their level of PTSD symptoms and the quality of their loved ones' last days. "We found that caregivers reported that their loved one's symptoms were poorly controlled and that the quality of the dying and death process was worse than that of other populations. In addition, family members who perceived that their loved one had either a lower quality of dying and death or poorly controlled pain symptoms, were more likely to have symptoms consistent with PTSD," said Cynthia Gries, M.D., M,Sc., of the Division of Pulmonary and Critical Care Medicine at the University of Washington School of Medicine in Seattle.
This is the first study to evaluate the caregivers' experience with end-of-life care in lung transplant patients, and to evaluate the psychological effects it has on those family members who survive. "Most people don't realize that prior to wait-listing a patient as a lung transplant candidate, a caregiver plan must exist to support the patient through the entire process," said Dr. Gries. That process can be lengthy and grueling for the caregiver as well as the patient, resulting in much higher rates of depression and PTSD symptoms. "The caregivers we studied had rates of depressive symptoms of 21 percent and of PTSD symptoms of 32 percent, compared to the average in the general population of six to seven percent," she continued. "This suggests that there is a significant burden of psychological symptoms in family members which has previously been unrecognized." The study demonstrates that there is an urgent need for significant improvement in areas such as symptom management. Dr. Gries believes that having trained counselors to help family members with emotional needs, as well as financial issues, could reduce the stress on caregivers. "We hope that our findings will increase awareness among clinicians that caregivers experience a significant burden of symptoms and may need additional support," she concluded. American Thoracic Society | |||||||||||||||||||||
|
Related Lung Transplant Current Events and Lung Transplant News Articles New clinical trial for patients with asbestos-associated lung cancer The Mesothelioma Center within the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital and Columbia University Medical Center is now recruiting patients for a clinical research study of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that is almost always caused by previous exposure to asbestos. UCSF marks a milestone with 500th transplant in heart and lung program UCSF marked a milestone this week with the 500th procedure in its Thoracic Transplant Program, which specializes in transplantation of the heart and lung. Lung transplants in cystic fibrosis patients with life-threatening bacteria sparks debate at ISHLT During Wednesday's Satellite Symposium 3: The Challenges of Lung Transplantation in Cystic Fibrosis (CF) at the International Society of Heart and Lung Transplantation (ISHLT) Annual Meeting & Scientific Sessions, clinicians and researchers discussed some of the unique challenges in achieving excellent lung transplant outcomes in patients with CF. Biomarkers may reduce need for biopsies Data presented at this week's 28th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) suggest the potential of a significant impact of using biomarkers to reduce the need for biopsies and personalize transplant patient care. Henry Ford Hospital to study effectiveness of a new procedure that may help emphysema suffers Researchers at Henry Ford Hospital today announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a significant new option for those suffering with advanced emphysema. Survival rates exceed national averages for UCSF heart, liver and lung transplant programs One-year survival rates for patients receiving heart, liver and lung transplants at UCSF Medical Center exceed national averages at statistically significant levels, according to new data compiled by the Scientific Registry of Transplant Recipients (SRTR). Researchers at Pulmonary Associates to study airway bypass procedure for severe emphysema Researchers at Pulmonary Associates today announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a new, minimally invasive option for those suffering with advanced widespread emphysema. New York Methodist Hospital to study airway bypass treatment for emphysema New York Methodist Hospital today announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a significant new, minimally-invasive option for those suffering with advanced widespread emphysema. Cigarettes leave deadly path by purging protective genes A University of Rochester scientist discovered that the toxins in cigarette smoke wipe out a gene that plays a vital role in protecting the body from the effects of premature aging. Transplant drug sirolimus shrinks tumors, improves lung function The drug sirolimus, normally used to help transplant patients fight organ rejection, may eventually be used as a less invasive treatment for a tumor called angiomyolipomata in patients with who would otherwise face surgery. More Lung Transplant Current Events and Lung Transplant News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||